Wallet Packaging
Product Description
Grünenthal GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Categories
Specifications
Grünenthal GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
More Products from Grünenthal GmbH (8)
-
Product Biopharma Assembly and Packaging
Biopharma Assembly and Packaging Services
We offer top yield rates, high flexibility and exceptional quality standards in assembly and packaging of pre-filled syringes (PFS), pre-filled pens (PFP) in all batch sizes via manual, semi-manual and automated technologies. -
Product Sterile Ampoule Filling/Packaging
Sterile Ampoule Filling/Packaging -
Product Integrated Manufacturing Services
Integrated Manufacturing Services -
Product Unit Dose Nasal Spray
Unit Dose Nasal Spray -
Product Tramadol HCl
Grünenthal GmbH offers a selected range of products which includes Tramadol HCl, as API, bulk and/ or finished dosage form. Please contact us for more information.
-
Product Betahistine 12.5 mg/ml Oral Drops
Glass bottle containing 100 ml oral solution with disposal pump. -
Product Betahistine diHCl
Grünenthal GmbH offers a selected range of products which includes Betahistine diHCl, as API, bulk tablets and/ or finished dosage form. Please contact us for more information.
-
Product Calcium carbonate + vit D3
Calcium carbonate + vit D3 tablets
Grünenthal GmbH resources (2)
-
News Grünenthal Responsibility Report 2024
As a recognised leader in environmental, social, and governance (ESG) matters, we proactively pursue best-in-class corporate sustainability practices. This report reflects the accomplishments of our teams worldwide around our focus areas of Patient People and Planet. Discover how our shared commitment is shaping long-term value. -
News Grünenthal Report 2024-2025
Grünenthal has a clear, bold vision: a World Free of Pain. In 2024, we took significant steps forward in developing innovative medicines for patients living with pain worldwide. The latest Grünenthal Report provides information about our key objectives and activities, recent business development highlights, and financial performance.





